UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma

Haematologica (Roma), 2024-01, Vol.109 (1), p.256

2024

Volltextzugriff (PDF)

FCGR3A F158V alleles frequency differs in multiple myeloma patients from healthy population

Oncoimmunology, 2024-08, Vol.13 (1), p.2388306

2024

Volltextzugriff (PDF)

Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma

Cell cycle (Georgetown, Tex.), 2013-06, Vol.12 (12), p.1811-1812

2013

Volltextzugriff (PDF)

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Blood, 2005-08, Vol.106 (3), p.1021-1030

2005

Volltextzugriff (PDF)

MMSET is overexpressed in cancers: Link with tumor aggressiveness

Biochemical and biophysical research communications, 2009-02, Vol.379 (4), p.840-845

2009

Volltextzugriff (PDF)

Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells

Oncogene, 2005-05, Vol.24 (21), p.3512-3524

2005

Volltextzugriff (PDF)

Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner

Nature communications, 2019-02, Vol.10 (1), p.910-910, Article 910

2019

Volltextzugriff (PDF)

Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer

BioMed research international, 2018-01, Vol.2018 (2018), p.1-5

2018

Volltextzugriff (PDF)

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Blood, 2009-04, Vol.113 (18), p.4331-4340

2009

Volltextzugriff (PDF)

Transcriptional Profiling of Leucocyte Count Variation from Porcine Peripheral Blood Reveals Differential Gene Expression

BioMed research international, 2018-01, Vol.2018 (2018), p.1-11

2018

Volltextzugriff (PDF)

CD38 antibodies in multiple myeloma

M.S. Médecine sciences, 2020-01, Vol.35 (12), p.1001

Moreaux, Jérôme

2020

Volltextzugriff (PDF)

RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators

Leukemia, 2021-05, Vol.35 (5), p.1451-1462

2021

Volltextzugriff (PDF)

STEAP1 is overexpressed in cancers: A promising therapeutic target

Biochemical and biophysical research communications, 2012-12, Vol.429 (3-4), p.148-155

2012

Volltextzugriff (PDF)

EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation

Leukemia, 2019-08, Vol.33 (8), p.2047-2060

2019

Volltextzugriff (PDF)

TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines

Haematologica (Roma), 2007-06, Vol.92 (6), p.803-811

2007

Volltextzugriff (PDF)

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

Blood, 2004-04, Vol.103 (8), p.3148-3157

2004

Volltextzugriff (PDF)

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma

Frontiers in genetics, 2019-09, Vol.10, p.861-861

2019

Volltextzugriff (PDF)

Input of DNA Microarrays to Identify Novel Mechanisms in Multiple Myeloma Biology and Therapeutic Applications

Clinical cancer research, 2007-12, Vol.13 (24), p.7289-7295

2007

Volltextzugriff (PDF)

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach

Frontiers in cell and developmental biology, 2022-06, Vol.10, p.879057-879057

2022

Volltextzugriff (PDF)

MRE11 and TREX1 control senescence by coordinating replication stress and interferon signaling

Nature communications, 2024-06, Vol.15 (1), p.5423-14, Article 5423

2024

Volltextzugriff (PDF)

EZH2 in normal hematopoiesis and hematological malignancies

Oncotarget, 2016-01, Vol.7 (3), p.2284-2296

2016

Volltextzugriff (PDF)

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

Haematologica (Roma), 2020-03, Vol.105 (3), p.784-795

2020

Volltextzugriff (PDF)

LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16136

2022

Volltextzugriff (PDF)

KDM6A controls immunogenicity in MM

Blood, 2024-10, Vol.144 (14), p.1465-1467

Moreaux, Jerome

2024

Volltextzugriff (PDF)

Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens

Scientific reports, 2024-09, Vol.14 (1), p.22432-12, Article 22432

2024

Volltextzugriff (PDF)

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma

FCGR3A F158V alleles frequency differs in multiple myeloma patients from healthy population

Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

MMSET is overexpressed in cancers: Link with tumor aggressiveness

Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells

Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner

Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Transcriptional Profiling of Leucocyte Count Variation from Porcine Peripheral Blood Reveals Differential Gene Expression

CD38 antibodies in multiple myeloma

RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators

STEAP1 is overexpressed in cancers: A promising therapeutic target

EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation

TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma

Input of DNA Microarrays to Identify Novel Mechanisms in Multiple Myeloma Biology and Therapeutic Applications

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach

MRE11 and TREX1 control senescence by coordinating replication stress and interferon signaling

EZH2 in normal hematopoiesis and hematological malignancies

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms

KDM6A controls immunogenicity in MM

Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens

Suchergebnisse filtern